Literature DB >> 22311089

The influence of follistatin on mechanical properties of bone tissue in growing mice with overexpression of follistatin.

Anna Gajos-Michniewicz1, Elzbieta Pawlowska, Tomasz Ochedalski, Agnieszka Piastowska-Ciesielska.   

Abstract

Mechanical competence of bones is mainly associated with tissue quality that depends on proper bone metabolism processes. An imbalance in the regulation of bone metabolism leads to pathological changes in bone tissue leading to susceptibility to bone fractures and bone deterioration processes. Bone metabolism is regulated to a large extent by the members of the transforming growth factor-β superfamily, i.e., activins and bone morphogenetic proteins. However, their function is regulated by a single-chain protein called follistatin (FS). The aim of this study was to test the hypothesis that overexpression of FS in growing mice results in impairments in bone morphology and mechanical properties. Moreover, we wanted to investigate how geometrical, structural and material properties of bone tissue change with age. The experiment was performed on growing C57BL/6 TgNK14-mFst/6J mice, overexpressing FS (F mice) versus C57BL/6J mice used as controls (C mice). To establish how overexpression of FS influences bone tissue quality, we studied mice femurs to determine geometrical, structural and material properties of the skeleton. To determine mechanical resistance of bone tissue, femurs were loaded to failure in a three-point bending test. Obtained results indicated that overexpression of FS negatively influences bone metabolism. It was found that mutation results with a significant decrease of all measured biomechanical strength variables in F mice in comparison to C mice. Overexpression of FS leads to decreased quality of skeleton, increasing susceptibility to bone fractures.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22311089     DOI: 10.1007/s00774-011-0347-8

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  23 in total

Review 1.  Too many follistatins: racing inside and getting out of the cell.

Authors:  T Rajendra Kumar
Journal:  Endocrinology       Date:  2005-12       Impact factor: 4.736

2.  The activin A-follistatin system: potent regulator of human extracellular matrix mineralization.

Authors:  Marco Eijken; Sigrid Swagemakers; Marijke Koedam; Cobie Steenbergen; Pieter Derkx; André G Uitterlinden; Peter J van der Spek; Jenny A Visser; Frank H de Jong; Huibert A P Pols; Johannes P T M van Leeuwen
Journal:  FASEB J       Date:  2007-04-20       Impact factor: 5.191

3.  A comparison of mechanical properties derived from multiple skeletal sites in mice.

Authors:  Jennifer L Schriefer; Alexander G Robling; Stuart J Warden; Adam J Fournier; James J Mason; Charles H Turner
Journal:  J Biomech       Date:  2005-03       Impact factor: 2.712

4.  Influence of a low dose of dietary soybean on bone properties and mineral status in young rats.

Authors:  Agnieszka Wanda Piastowska-Ciesielska; Mikolaj Antoni Gralak
Journal:  Biofactors       Date:  2010-08-30       Impact factor: 6.113

5.  Rat anterior pituitary folliculostellate cells are targets of interleukin-1beta and a major source of intrapituitary follistatin.

Authors:  Louise M Bilezikjian; Angela M O Leal; Amy L Blount; Anne Z Corrigan; Andrew V Turnbull; Wylie W Vale
Journal:  Endocrinology       Date:  2003-02       Impact factor: 4.736

6.  Differential gene expression and regulation of the bone morphogenetic protein antagonists follistatin and gremlin in normal and osteoarthritic human chondrocytes and synovial fibroblasts.

Authors:  Ginette Tardif; David Hum; Jean-Pierre Pelletier; Christelle Boileau; Pierre Ranger; Johanne Martel-Pelletier
Journal:  Arthritis Rheum       Date:  2004-08

Review 7.  Follistatin: a multifunctional regulatory protein.

Authors:  D J Phillips; D M de Kretser
Journal:  Front Neuroendocrinol       Date:  1998-10       Impact factor: 8.606

Review 8.  Regulation of ovarian function by the TGF-beta superfamily and follistatin.

Authors:  Shyr-Yeu Lin; John R Morrison; David J Phillips; David M de Kretser
Journal:  Reproduction       Date:  2003-08       Impact factor: 3.906

9.  Differential distribution of follistatin isoforms: application of a new FS315-specific immunoassay.

Authors:  Alan L Schneyer; Qifa Wang; Yisrael Sidis; Patrick M Sluss
Journal:  J Clin Endocrinol Metab       Date:  2004-10       Impact factor: 5.958

Review 10.  Sex hormones, their receptors and bone health.

Authors:  K Venken; F Callewaert; S Boonen; D Vanderschueren
Journal:  Osteoporos Int       Date:  2008-04-05       Impact factor: 4.507

View more
  10 in total

Review 1.  Clinical and Therapeutic Implications of Follistatin in Solid Tumours.

Authors:  Lei Shi; Jeyna Resaul; Sioned Owen; Lin Ye; Wen G Jiang
Journal:  Cancer Genomics Proteomics       Date:  2016 11-12       Impact factor: 4.069

Review 2.  Follistatin as potential therapeutic target in prostate cancer.

Authors:  Maria Vittoria Sepporta; Francesca Maria Tumminello; Carla Flandina; Marilena Crescimanno; Marco Giammanco; Maurizio La Guardia; Danila di Majo; Gaetano Leto
Journal:  Target Oncol       Date:  2013-03-01       Impact factor: 4.493

3.  Follistatin in chondrocytes: the link between TRPV4 channelopathies and skeletal malformations.

Authors:  Holly A Leddy; Amy L McNulty; Suk Hee Lee; Nicole E Rothfusz; Bernd Gloss; Margaret L Kirby; Mary R Hutson; Daniel H Cohn; Farshid Guilak; Wolfgang Liedtke
Journal:  FASEB J       Date:  2014-02-27       Impact factor: 5.191

4.  Elevated Levels of Peripheral Kynurenine Decrease Bone Strength in Rats with Chronic Kidney Disease.

Authors:  Bartlomiej Kalaska; Krystyna Pawlak; Tomasz Domaniewski; Ewa Oksztulska-Kolanek; Beata Znorko; Alicja Roszczenko; Joanna Rogalska; Malgorzata M Brzoska; Pawel Lipowicz; Michal Doroszko; Anna Pryczynicz; Dariusz Pawlak
Journal:  Front Physiol       Date:  2017-10-31       Impact factor: 4.566

5.  Gene therapy for follistatin mitigates systemic metabolic inflammation and post-traumatic arthritis in high-fat diet-induced obesity.

Authors:  Ruhang Tang; Natalia S Harasymowicz; Chia-Lung Wu; Kelsey H Collins; Yun-Rak Choi; Sara J Oswald; Farshid Guilak
Journal:  Sci Adv       Date:  2020-05-08       Impact factor: 14.136

6.  Hyperglycemia compromises Rat Cortical Bone by Increasing Osteocyte Lacunar Density and Decreasing Vascular Canal Volume.

Authors:  Birol Ay; Kushagra Parolia; Robert S Liddell; Yusheng Qiu; Giovanni Grasselli; David M L Cooper; John E Davies
Journal:  Commun Biol       Date:  2020-01-09

7.  Bone Geometry Is Altered by Follistatin-Induced Muscle Growth in Young Adult Male Mice.

Authors:  Audrey S M Chan; Narelle E McGregor; Ingrid J Poulton; Justin P Hardee; Ellie H-J Cho; T John Martin; Paul Gregorevic; Natalie A Sims; Gordon S Lynch
Journal:  JBMR Plus       Date:  2021-03-03

8.  A mesenchymal stromal cell gene signature for donor age.

Authors:  Hugo Alves; Jetty van Ginkel; Nathalie Groen; Marc Hulsman; Anouk Mentink; Marcel Reinders; Clemens van Blitterswijk; Jan de Boer
Journal:  PLoS One       Date:  2012-08-23       Impact factor: 3.240

9.  A link between central kynurenine metabolism and bone strength in rats with chronic kidney disease.

Authors:  Bartlomiej Kalaska; Krystyna Pawlak; Ewa Oksztulska-Kolanek; Tomasz Domaniewski; Beata Znorko; Malgorzata Karbowska; Aleksandra Citkowska; Joanna Rogalska; Alicja Roszczenko; Malgorzata M Brzoska; Dariusz Pawlak
Journal:  PeerJ       Date:  2017-04-20       Impact factor: 2.984

10.  Profiling the miRNA-mRNA-lncRNA interaction network in MSC osteoblast differentiation induced by (+)-cholesten-3-one.

Authors:  Qiuke Hou; Yongquan Huang; Yamei Liu; Yiwen Luo; Bin Wang; Rudong Deng; Saixia Zhang; Fengbin Liu; Dongfeng Chen
Journal:  BMC Genomics       Date:  2018-10-29       Impact factor: 3.969

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.